Manufacturing

Articles

Catalent’s acquisition of Paragon Bioservices will provide expertise and in expanding gene and cell therapy markets.

Catalent to Acquire Paragon Bioservices for $1.2 Billion

Agnes Shanley is senior editor of Pharmaceutical Technology.

At INTERPHEX 2019, CEO Richard Johnson highlighted the importance of PDA’s new Asian business unit and outlined the organization’s plans. Data integrity guidance for manufacturing and quality systems will be published by the end of the year, as efforts move into big data and artificial intelligence.

PDA Strengthens its Global Presence

Adding to an existing $115-million investment, the 700,000-ft2 site in Longmont, CO will expand AveXis’ gene-therapy manufacturing capacity.

Novartis’ AveXis to Acquire Manufacturing Site for Gene Therapies

NJII and Pall collaborate to address biomanufacturing technology and workforce development challenges.

NJII and Pall Partner on Cell and Gene Therapy Manufacturing Development

Valitacell, Solentim, and Microcoat were awarded EUR 3.5 million (US$4 million) to produce an integrated platform to deposit, culture, profile, and select optimal cells for biologic drug manufacturing.

Valitacell, Solentim Funded for Biologics and Cell Therapy Development

Belgium-based CDMO MaSTherCell will expand its European manufacturing capacity for cell and gene therapy products by setting up a new facility in Belgium. 

MaSTherCell Announces New Commercial Manufacturing Facility for Cell and Gene Therapies

Walter Colasante is a vice-president in Charles River Associates’ (CRA’s) Life Sciences Practice. 

Pascale Diesel is a vice-president in Charles River Associates’ (CRA’s) Life Sciences Practice.

Think ahead to production requirements when planning strategies in early development of gene and cell therapies.

The Link Between Manufacturing and Commercialization in Gene and Cell Therapy

The companies aim to assess automated CAR-T cell therapy manufacturing at the point-of-care and develop technologies to facilitate patient access to immunotherapies.

Lonza, Sheba to Collaborate on Automated Cell-Therapy Manufacturing

The companies will join forces to improve gene- and cell-therapy manufacturing using the cloud and machine learning.

Oxford Biomedica, Microsoft Announce R&D Collaboration

The new facility, located at the company’s headquarters in Pittsburgh, PA, is expected to meet all clinical and commercial development needs of the company’s lead gene therapy program.

Manufacturing, Cell Therapies